adenosine has been researched along with Niemann-Pick Disease, Type C in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bernardo, A; De Nuccio, C; De Simone, R; Ferrante, A; Matteucci, A; Pepponi, R; Popoli, P; Visentin, S | 1 |
Bernardo, A; De Nuccio, C; Ferrante, A; Minghetti, L; Pepponi, R; Popoli, P; Visentin, S | 1 |
Bernardo, A; De Nuccio, C; Ferrante, A; Martire, A; Minghetti, L; Pepponi, R; Popoli, P; Visentin, S | 1 |
Ling, SC; Luo, JH; Xu, SJ; Yan, YG; Yu, HM; Zhou, SY | 1 |
Li, Q; Shen, Y; Su, LD; Sun, CL; Wang, XX | 1 |
5 other study(ies) available for adenosine and Niemann-Pick Disease, Type C
Article | Year |
---|---|
Repurposing Dipyridamole in Niemann Pick Type C Disease: A Proof of Concept Study.
Topics: Adenosine; Animals; Dipyridamole; Drug Repositioning; Humans; Mice; Niemann-Pick Disease, Type C; Proof of Concept Study | 2022 |
The stimulation of adenosine A2A receptors ameliorates the pathological phenotype of fibroblasts from Niemann-Pick type C patients.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Calcium; Case-Control Studies; Cell Line; Cholesterol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Electron Transport Complex IV; Extracellular Signal-Regulated MAP Kinases; Female; Fibroblasts; Humans; Lysosomes; Male; Membrane Potential, Mitochondrial; Mitochondria; Niemann-Pick Disease, Type C; Phenethylamines; Phenotype; Receptor, Adenosine A2A; Triazines; Triazoles | 2013 |
Stimulation of adenosine A2A receptors reduces intracellular cholesterol accumulation and rescues mitochondrial abnormalities in human neural cell models of Niemann-Pick C1.
Topics: Adenosine; Adenosine A2 Receptor Agonists; Calcium; Carrier Proteins; Cell Line, Tumor; Cell Membrane; Cholesterol; Cyclic AMP-Dependent Protein Kinases; Humans; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mitochondria; Neurons; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Oligodendroglia; Phenethylamines; Receptor, Adenosine A2A | 2016 |
Decreased purinergic inhibition of synaptic activity in a mouse model of Niemann-Pick disease type C.
Topics: Adenosine; Animals; CA1 Region, Hippocampal; Disease Models, Animal; Electrophysiological Phenomena; Excitatory Postsynaptic Potentials; Hippocampus; Humans; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Long-Term Potentiation; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Mutant Proteins; Niemann-Pick C1 Protein; Niemann-Pick Disease, Type C; Proteins; Receptor, Adenosine A1; Synapses; Synaptic Transmission | 2011 |
Cerebellar long-term depression is deficient in Niemann-Pick type C disease mice.
Topics: Adenosine; Adenosine Triphosphate; Animals; Cerebellum; Electrophysiological Phenomena; Excitatory Postsynaptic Potentials; gamma-Aminobutyric Acid; Mice; Mice, Knockout; Neuronal Plasticity; Niemann-Pick Disease, Type C; Patch-Clamp Techniques; Presynaptic Terminals; Purkinje Cells; Receptor, Adenosine A1; Reverse Transcriptase Polymerase Chain Reaction; Synaptic Transmission | 2011 |